https://www.selleckchem.com/pr....oducts/pclx-001-ddd8
86; 95% confidence interval, 1.03-3.37). After 8 weeks from the beginning of chemotherapy, CEA reduction rate of 50% and CEA-specific growth lower than-0.5%/day are effective prognostic factors among patients with high serum CEA levels and could become useful intermediate endpoints of clinical trials. After 8 weeks from the beginning of chemotherapy, CEA reduction rate of 50% and CEA-specific growth lower than -0.5%/day are effective prognostic factors among patients with high serum CEA levels and could become useful intermedi